Creative Medical Technology
CELZ
11 hedge funds and large institutions have $199K invested in Creative Medical Technology in 2026 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 6 closing their positions.
0% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 6
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
2.38% less ownership
Funds ownership: 4.99% → 2.62% (-2.4%)
21% less capital invested
Capital invested by funds: $253K → $199K (-$53.2K)
21% less funds holding
Funds holding: 14 → 11 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$27.9K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$20.5K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$19.2K |
| 4 |
Wells Fargo
San Francisco,
California
|
+$9.78K |
| 5 |
Morgan Stanley
New York
|
+$978 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$59.2K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$34.2K |
| 3 |
DS
DRW Securities
Chicago,
Illinois
|
-$20.2K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$10.1K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$2.21K |
CELZ Hedge Fund Activity: Q1 2026 in Review
11 of the 8,134 institutional investors tracked by Wall St. Rank reported a position in Creative Medical Technology (CELZ) for Q1 2026, worth a combined $199K — down 21% from $253K a quarter earlier.
Fund positioning in CELZ was balanced in Q1 2026: 6 funds opened new positions, 6 closed out, 2 added to existing stakes and 2 trimmed.
The largest buyer was XTX Topco, opening a new position worth an estimated $27.9K. The largest seller was Jane Street, exiting entirely with an estimated $59.2K sold.
- 11 institutional investors held Creative Medical Technology (CELZ) as of Q1 2026, down from 14 in Q4 2025.
- Funds reported $199K of Creative Medical Technology stock for Q1 2026, down 21% quarter-over-quarter.
- 6 funds opened new Creative Medical Technology positions in Q1 2026 and 6 closed out, a net change of 0 holders.
- The largest Creative Medical Technology buyer in Q1 2026 was XTX Topco, an estimated $27.9K added.
- The largest Creative Medical Technology seller in Q1 2026 was Jane Street, an estimated $59.2K sold.
Based on aggregated 13F filings for Q1 2026.